Nationally Notifiable Infectious Diseases and Conditions, United States: Annual Tables

TABLE 7. Reported cases of notifiable diseases and rates per 100,000 population, by ethnicity*, excluding U.S. territories - - United States, 2017
Disease Hispanic Non-Hispanic Ethnicity not stated Total
No. Rate No. Rate No. No.
Anthrax — — — — — —
Arboviral diseases
Chikungunya virus disease 11 0.02 95 0.04 50 156
Eastern equine encephalitis virus disease
Neuroinvasive S S S S S 5
Non-neuroinvasive — — — — — —
Jamestown Canyon virus disease
Neuroinvasive — — 38 0.01 20 58
Non-neuroinvasive S S S S S 17
La Crosse virus disease
Neuroinvasive 3 0.01 52 0.02 8 63
Non-neuroinvasive — — — — — —
Powassan virus disease
Neuroinvasive — — 13 0.00 20 33
Non-neuroinvasive S S S S S 1
St. Louis encephalitis virus disease
Neuroinvasive S S S S S 6
Non-neuroinvasive S S S S S 5
West Nile virus disease
Neuroinvasive 208 0.35 982 0.37 235 1,425
Non-neuroinvasive 45 0.08 470 0.18 157 672
Western equine encephalitis virus disease
Neuroinvasive — — — — — —
Non-neuroinvasive — — — — — —
Babesiosis
Total 103 0.21 1,345 0.66 920 2,368
Confirmed 97 0.20 1,119 0.55 778 1,994
Probable 6 0.01 226 0.11 142 374
Botulism
Total 44 0.07 95 0.04 38 177
Foodborne S S S S S 19
Infant † 28 2.72 82 2.82 27 137
Other (wound & unspecified) S S S S S 21
Brucellosis 58 0.10 53 0.02 29 140
Campylobacteriosis 8,573 14.54 38,816 14.55 20,148 67,537
Chancroid S S S S S 7
Chlamydia trachomatis infection 232,231 393.97 851,358 319.13 624,980 1,708,569
Cholera S S S S S 10
Coccidioidomycosis § 2,382 9.59 4,617 4.33 7,365 14,364
Cryptosporidiosis
Total 1,205 2.04 7,477 2.80 2,732 11,414
Confirmed 937 1.59 5,217 1.96 1,889 8,043
Probable 268 0.45 2,260 0.85 843 3,371
Cyclosporiasis 162 0.29 756 0.32 276 1,194
Dengue virus infections 
Dengue 79 0.13 236 0.09 122 437
Dengue-like illness S S S S S 8
Severe dengue S S S S S 9
Diphtheria — — — — — —
Ehrlichiosis and Anaplasmosis
Anaplasma phagocytophilum infection 73 0.13 3,510 1.36 2,179 5,762
Ehrlichia chaffeensis infection 40 0.07 1,137 0.44 465 1,642
Ehrlichia ewingii infection — — 39 0.02 6 45
Undetermined ehrlichiosis/anaplasmosis 3 0.01 195 0.08 71 269
Giardiasis 1,059 2.43 8,451 3.98 5,683 15,193
Gonorrhea 65,367 110.89 334,013 125.21 156,228 555,608
Haemophilus influenzae, invasive disease
All ages, all serotypes 313 0.53 3,731 1.40 1,504 5,548
Age <5 years **
Serotype b 2 0.04 24 0.16 7 33
Non-b serotype 18 0.35 123 0.83 48 189
Nontypeable 31 0.60 114 0.77 55 200
Unknown serotype 31 0.60 123 0.83 49 203
Hansen's disease 16 0.03 53 0.02 25 94
Hantavirus infection, non-hantavirus pulmonary syndrome S S S S S 2
Hantavirus pulmonary syndrome 3 0.01 23 0.01 7 33
Hemolytic uremic syndrome post-diarrheal 29 0.05 261 0.10 48 338
Hepatitis ††
A, acute 471 0.80 2,285 0.86 609 3,365
B, acute 196 0.33 2,379 0.90 834 3,409
B, perinatal infection §§ 1 0.05 23 0.40 7 31
C, acute 289 0.51 2,838 1.12 1,098 4,225
Confirmed 235 0.42 2,152 0.85 826 3,213
Probable 54 0.10 686 0.27 272 1,012
Human immunodeficiency virus diagnoses 7,995 13.56 25,943 9.72 — 33,938
Influenza-associated pediatric mortality ¶¶ 23 0.12 91 0.17 12 126
Invasive pneumococcal disease ***
All ages 1,519 4.00 12,306 6.01 5,955 19,780
Confirmed 1,513 3.98 12,232 5.97 5,875 19,620
Probable 6 0.02 74 0.04 80 160
Age <5 years ** 202 0.49 723 0.33 309 1,234
Confirmed 200 5.51 717 5.81 303 1,220
Probable 2 0.06 6 0.05 6 14
Legionellosis 435 0.74 5,500 2.06 1,523 7,458
Leptospirosis 8 0.02 43 0.02 21 72
Listeriosis 125 0.21 619 0.23 143 887
Lyme disease
Total 667 1.13 17,247 6.50 24,829 42,743
Confirmed 443 0.75 11,570 4.36 17,500 29,513
Probable 224 0.38 5,677 2.14 7,329 13,230
Malaria 35 0.06 1,608 0.60 413 2,056
Measles
Total 6 0.01 103 0.04 11 120
Indigenous 3 0.01 90 0.03 6 99
Imported 3 0.01 13 0.00 5 21
Meningococcal disease
All serogroups 46 0.08 231 0.09 76 353
Serogroups ACWY 22 0.04 71 0.03 14 107
Serogroup B 5 0.01 63 0.02 22 90
Other serogroups 4 0.01 12 0.00 9 25
Unknown serogroup 15 0.03 85 0.03 31 131
Mumps 610 1.03 4,202 1.58 1,297 6,109
Novel Influenza A virus infections 5 0.01 46 0.02 15 66
Pertussis 3,073 5.21 11,525 4.32 4,377 18,975
Plague S S S S S 5
Poliomyelitis, paralytic — — — — — —
Poliovirus infection, nonparalytic — — — — — —
Psittacosis S S S S S 5
Q fever
Total 30 0.05 115 0.04 48 193
Acute 23 0.04 94 0.04 36 153
Chronic 7 0.01 21 0.01 12 40
Rabies
Human S S S S S 2
Rubella S S S S S 7
Rubella, congenital syndrome † S S S S S 5
Salmonellosis 8,038 13.64 32,849 12.31 13,398 54,285
Severe acute respiratory syndrome-associated coronavirus disease — — — — — —
Shiga toxin-producing Escherichia coli ††† 1,314 2.23 5,351 2.01 2,007 8,672
Shigellosis 3,559 6.04 8,524 3.20 2,829 14,912
Smallpox — — — — — —
Spotted fever rickettsiosis
Total 144 0.25 4,388 1.66 1,716 6,248
Confirmed 6 0.01 109 0.04 61 176
Probable 138 0.23 4,279 1.62 1,655 6,072
Streptococcal toxic shock syndrome 31 0.13 272 0.15 69 372
Syphilis
Total, all stages 26,658 45.22 67,346 25.24 7,563 101,567
Congenital † 308 29.88 593 20.39 17 918
Primary and secondary 6,790 11.52 21,991 8.24 1,863 30,644
Tetanus 3 0.01 22 0.01 8 33
Toxic shock syndrome (other than Streptococcal) — — 18 0.01 12 30
Trichinellosis S S S S S 15
Tuberculosis 2,568 4.36 6,532 2.45 5 9,105
Tularemia 12 0.02 178 0.07 49 239
Typhoid fever 40 0.07 322 0.12 57 419
Vancomycin-intermediate Staphylococcus aureus 11 0.03 72 0.03 26 109
Vancomycin-resistant Staphylococcus aureus S S S S S 3
Varicella morbidity 1,275 2.43 5,271 2.47 2,229 8,775
Varicella mortality U U U U U U
Vibriosis
Total 208 0.36 1,408 0.54 469 2,085
Confirmed 134 0.23 1,014 0.39 349 1,497
Probable 74 0.13 394 0.15 120 588
Viral hemorrhagic fevers
Crimean-Congo hemorrhagic fever virus — — — — — —
Ebola virus — — — — — —
Guanarito virus — — — — — —
Junin virus — — — — — —
Lassa virus — — — — — —
Lujo virus — — — — — —
Machupo virus — — — — — —
Marburg virus — — — — — —
Sabia virus — — — — — —
Yellow fever — — — — — —
Zika virus
Zika virus disease, congenital †,§§§ S S S S S 22
Zika virus disease, non-congenital 241 0.41 133 0.05 123 497
Zika virus infection, congenital †,§§§ S S S S S 17
Zika virus infection, non-congenital 328 0.56 173 0.06 140 641
  • —: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • U: Unavailable — The data are unavailable.
  • S: Suppressed
  • * Conditions with <25 cases reported in the year were not broken down by ethnicity.
  • † The rate is calculated using population less than 1 year of age.
  • § Reportable in <25 states.
  • ¶ Total number of reported laboratory-positive dengue cases, including all confirmed cases [by anti-dengue virus (DENV) molecular diagnostic methods or seroconversion of anti-DENV IgM] and all probable cases (by a single, positive anti-DENV IgM).
  • ** The rate is calculated using population less than 5 years of age.
  • †† Chronic hepatitis B and C data are not included in NNDSS tables but reported case counts are included in the annual Summary of Viral Hepatitis, published online by CDC's Division of Viral Hepatitis, available at https://www.cdc.gov/hepatitis/statistics/2016surveillance/index.htm.
  • §§ The rate is calculated using population less than 2 years of age.
  • ¶¶ The rate is calculated using population less than 18 years of age.
  • *** Includes drug resistant and susceptible cases of Invasive Pneumococcal Disease. This condition was previously named Streptococcus pneumoniae invasive disease and cases were reported to CDC using different event codes to specify whether the cases were drug resistant or in a defined age group, such as <5 years.
  • ††† Includes Escherichia coli O157:H7 and Shiga toxin-positive Escherichia coli (including O157, non-O157, and not serogrouped).
  • §§§ Data reported to ArboNET using the national surveillance case definition for congenital Zika virus disease or infection (CSTE Position Statement 16-ID-01). Additional data reported to the US Zika Pregnancy Registry for outcomes of pregnancies with laboratory evidence of possible Zika virus infection are available at https://www.cdc.gov/pregnancy/zika/data/pregnancy-outcomes.html. Cases reported to the US Zika Pregnancy Registry might not meet the national surveillance case definition for congenital Zika virus disease or infection.
Notes:
  • These are annual cases of selected infectious national notifiable diseases from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data reported by the 50 states, New York City, the District of Columbia, and the U.S. territories are collated and published. Cases are reported by state health departments to CDC weekly. Because source datasets may be updated as additional information is received, statistics in publications based on that source data may differ from what is presented in these tables.
  • The list of nationally notifiable infectious diseases and conditions for 2018 and their national surveillance case definitions are available by navigating to the Surveillance Case Definitions | CDC web page, selecting "2017" for the notifiable condition list year, checking "infectious" conditions, and clicking "Get Notifiable List by Year". This list incorporates the Council of State and Territorial Epidemiologists (CSTE) position statements approved in 2016 by CSTE for national surveillance, that were implemented in January 2017, including updated surveillance case definitions for salmonellosis, shigellosis, vibrioisis, perinatal hepatitis B virus infection, invasive pneumococcal disease, Lyme disease, and tularemia reported through August 7, 2018. Publication criteria for the finalized 2017 data are available at https://wonder.cdc.gov/nndss/documents/2017_NNDSS_Publication_Criteria.pdf. See also Guide to Interpreting Provisional and Finalized NNDSS Data.
  • Population estimates for incidence rates are July 1st, 2017 estimates obtained from the National Center for Health Statistics (NCHS) postcensal estimates of the resident population of the United States for April 1, 2010 - July 1, 2017, by year, county, single year of age (range: 0 to 85 years), bridged-race (white, black or African American, American Indian or Alaska Native, Asian, or Pacific Islander), Hispanic ethnicity (not Hispanic or Latino, Hispanic or Latino), and sex (Vintage 2017), prepared under a collaborative arrangement with the U.S. Census Bureau. Population estimates for states released June 27, 2018 are available at https://www.cdc.gov/nchs/nvss/bridged_race/data_documentation.htm. Population estimates for territories are the 2017 mid-year estimates from the U.S. Census Bureau International Data Base, accessed on October 2, 2018 at https://www.census.gov/data-tools/demo/idb/informationGateway.php. The choice of population denominators for incidence is based on the availability of population data at the time of publication preparation.
  • Annual tables for 2016 and later years are available on CDC WONDER.
  • Annual summary reports from 1993-2015 are available as published in the MMWR.
  • NNDSS annual tables since 1952 are available at CDC Stacks (once in CDC Stacks select "Annual Reports" in the "Genre" box to the left).
Suggested Citation: